| Literature DB >> 33687517 |
Abstract
There is a need of comparative studies to understand the differences in term of efficacy and safety of drugs with different mechanisms of action but similar therapeutic indications. This requires changes in the European Legislation of criteria for drug approval.Entities:
Keywords: Added value; Drugs; Efficacy; Quality; Safety
Mesh：
Substances：
Year: 2021 PMID： 33687517 DOI： 10.1007/s00228-021-03110-3
Source DB: PubMed Journal: Eur J Clin Pharmacol ISSN： 0031-6970 Impact factor: 2.953